Summary
Definition
Anamnesis y examen
Principales factores de diagnóstico
- firm, nontender, red or pink-to-violaceous or skin-colored papule or subcutaneous nodule
- rapidly growing lesion
Otros factores de diagnóstico
- enlarged lymph nodes
- ulceration or bleeding cutaneous lesion
- small papules or nodules surrounding a primary lesion
Factores de riesgo
- cumulative ultraviolet (UV) exposure
- immunosuppression
- advancing age
- male sex
- white skin
- Merkel cell polyomavirus (MCPyV) infection with oncogenic transformation
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- biopsy and histopathologic assessment
- dermoscopy
Pruebas diagnósticas que deben considerarse
- lymph node ultrasound
- whole-body PET scan
- CT scan with contrast chest/abdomen/pelvis (± neck)
- brain MRI
- fine-needle aspiration or core biopsy
- sentinel lymph node biopsy (SLNB)
- Merkel cell polyomavirus serology
Pruebas emergentes
- circulating tumor DNA (ctDNA) analysis
Algoritmo de tratamiento
localized disease: stage I or II (T-any cN0 M0)
regional disease: stage IIIA
regional disease: unknown primary tumor with clinically apparent nodal disease
regional disease: stage IIIB
distant metastatic disease: stage IV
Colaboradores
Autores
Kelly Harms, MD, PhD
Associate Professor of Dermatology
Michigan Medicine
University of Michigan
Ann Arbor
MI
Divulgaciones
KH is a panel member for NCCN guidelines on Merkel cell carcinoma. She serves as Chair of Professionalism and Ethics for the Michigan Dermatological Society Board of Directors. KH is married to Paul Harms, a co-author of research on Merkel cell carcinoma.
Alison Lee, MD, MHS
Assistant Professor
Department of Dermatology
Emory University
Atlanta, GA
Divulgaciones
AL declares that she has no competing interests.
Revisores por pares
Isaac Brownell, MD, PhD
Senior Investigator
Dermatology Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health (NIH)
Bethesda
MD
Divulgaciones
IB declares that he has no competing interests.
Zoe Venables, MbChB, MMedSci, MRCP
Clinical Associate Professor and Consultant Dermatologist
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich
UK
Divulgaciones
ZV declares that she has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma [internet publication].Texto completo
Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.Texto completo Resumen
Lugowska I, Becker JC, Ascierto PA, et al; ESMO Guidelines Committee. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024 May;9(5):102977.Texto completo Resumen
Silk AW, Barker CA, Bhatia S, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. J Immunother Cancer. 2022 Jul;10(7):e004434.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

Diferenciales
- Basal cell carcinoma (BCC)
- Squamous cell carcinoma (SCC) of the skin
- Amelanotic/hypomelanotic melanoma
Más DiferencialesGuías de práctica clínica
- NCCN clinical practice guidelines in oncology: Merkel cell carcinoma
- Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up
Más Guías de práctica clínicaInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad